Pro-Dex, Inc. (PDEX): Price and Financial Metrics


Pro-Dex, Inc. (PDEX): $23.81

-1.03 (-4.15%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

PDEX POWR Grades


  • PDEX scores best on the Sentiment dimension, with a Sentiment rank ahead of 94.59% of US stocks.
  • The strongest trend for PDEX is in Stability, which has been heading down over the past 66 days.
  • PDEX ranks lowest in Growth; there it ranks in the 19th percentile.

PDEX Stock Summary

  • Pro Dex Inc's market capitalization of $90,918,399 is ahead of merely 14.12% of US-listed equities.
  • Price to trailing twelve month operating cash flow for PDEX is currently 60.17, higher than 93.79% of US stocks with positive operating cash flow.
  • With a year-over-year growth in debt of 128.92%, Pro Dex Inc's debt growth rate surpasses 92.23% of about US stocks.
  • Stocks that are quantitatively similar to PDEX, based on their financial statements, market capitalization, and price volatility, are FORM, ALBO, MITK, AAOI, and KN.
  • Visit PDEX's SEC page to see the company's official filings. To visit the company's web site, go to www.pro-dex.com.

PDEX Valuation Summary

  • PDEX's price/sales ratio is 2.3; this is 79.74% lower than that of the median Healthcare stock.
  • PDEX's price/sales ratio has moved up 2 over the prior 243 months.
  • Over the past 243 months, PDEX's EV/EBIT ratio has gone up 7.4.

Below are key valuation metrics over time for PDEX.

Stock Date P/S P/B P/E EV/EBIT
PDEX 2021-08-31 2.3 4.5 15.0 12.9
PDEX 2021-08-30 2.4 4.6 15.3 13.1
PDEX 2021-08-27 2.4 4.7 15.6 13.4
PDEX 2021-08-26 2.8 5.5 18.2 15.4
PDEX 2021-08-25 2.9 5.6 18.7 15.8
PDEX 2021-08-24 2.9 5.6 18.6 15.7

PDEX Growth Metrics

    The 5 year cash and equivalents growth rate now stands at 201.52%.
  • Its 3 year revenue growth rate is now at 39.43%.
  • Its 5 year revenue growth rate is now at 62.11%.
Over the past 49 months, PDEX's revenue has gone up $17,451,000.

The table below shows PDEX's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-09-30 39.427 1.511 4.249
2021-06-30 38.029 -2.078 4.45
2021-03-31 39.718 -0.156 6.142
2020-12-31 36.487 3.472 5.36
2020-09-30 36.183 3.149 6.272
2020-06-30 34.834 4.945 6.112

PDEX's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • PDEX has a Quality Grade of C, ranking ahead of 55.91% of graded US stocks.
  • PDEX's asset turnover comes in at 1.002 -- ranking 19th of 186 Medical Equipment stocks.
  • APEN, ZBH, and BDX are the stocks whose asset turnover ratios are most correlated with PDEX.

The table below shows PDEX's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 1.002 0.357 0.150
2021-03-31 1.114 0.371 0.230
2020-12-31 1.136 0.372 0.237
2020-09-30 1.217 0.382 0.312
2020-06-30 1.201 0.377 0.316
2020-03-31 1.112 0.371 0.260

PDEX Price Target

For more insight on analysts targets of PDEX, see our PDEX price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $39.00 Average Broker Recommendation 1.5 (Moderate Buy)

PDEX Stock Price Chart Interactive Chart >

Price chart for PDEX

PDEX Price/Volume Stats

Current price $23.81 52-week high $38.45
Prev. close $24.84 52-week low $20.06
Day low $23.33 Volume 2,080
Day high $24.20 Avg. volume 6,382
50-day MA $23.46 Dividend yield N/A
200-day MA $27.40 Market Cap 87.14M

Pro-Dex, Inc. (PDEX) Company Bio


Pro-Dex, Inc. products and distributes medical and dental equipment. The Company offers micro-air motors, surgical drivers, and precision air powered motors. Pro-Dex markets its products in the United States.


PDEX Latest News Stream


Event/Time News Detail
Loading, please wait...

PDEX Latest Social Stream


Loading social stream, please wait...

View Full PDEX Social Stream

Latest PDEX News From Around the Web

Below are the latest news stories about Pro Dex Inc that investors may wish to consider to help them evaluate PDEX as an investment opportunity.

Pro-Dex, Inc.'s (NASDAQ:PDEX) Stock Is Going Strong: Is the Market Following Fundamentals?

Most readers would already be aware that Pro-Dex's (NASDAQ:PDEX) stock increased significantly by 13% over the past...

Yahoo | January 5, 2022

Contrasting Pro-Dex (PDEX) & The Competition

Pro-Dex (NASDAQ: PDEX) is one of 196 public companies in the Surgical & medical instruments industry, but how does it contrast to its peers? We will compare Pro-Dex to related businesses based on the strength of its earnings, dividends, institutional ownership, valuation, risk, profitability and analyst recommendations. Analyst Ratings This is a summary of current []

Dakota Financial News | December 17, 2021

Contrasting Pro-Dex (PDEX) and The Competition

Pro-Dex (NASDAQ: PDEX) is one of 195 public companies in the Surgical & medical instruments industry, but how does it compare to its competitors? We will compare Pro-Dex to related businesses based on the strength of its analyst recommendations, dividends, profitability, valuation, earnings, institutional ownership and risk. Profitability This table compares Pro-Dex and its competitors []

Transcript Daily | December 9, 2021

Great news for Pro-Dex, Inc. (NASDAQ:PDEX): Insiders acquired stock in large numbers last year

It is usually uneventful when a single insider buys stock. However, When quite a few insiders buy shares, as it...

Yahoo | December 6, 2021

Long Cast Advisers on Pro-Dex (PDEX): We are Happy to Patiently Invest Alongside

No summary available.

Insider Monkey | December 2, 2021

Read More 'PDEX' Stories Here

PDEX Price Returns

1-mo -0.75%
3-mo -1.90%
6-mo -22.39%
1-year -25.36%
3-year 61.31%
5-year 347.56%
YTD 2.59%
2021 -25.06%
2020 76.47%
2019 45.28%
2018 77.65%
2017 44.68%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.7788 seconds.